SCHEMBL6163420

SCHEMBL6163420

COC(=O)c1oc(C(C)(C)C)cc1NC(=O)Nc1ccc(N(C)c2ccncc2)c2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 11/20 0.51
RAF1 P04049 4/20 0.51
GAA P10253 1/20 0.42
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 1/20 0.41
ALDH1A1 P00352 2/20 0.37
MAPK12 P53778 2/20 0.34
TNF P01375 1/20 0.34
HCK P08631 1/20 0.34
KDM4E B2RXH2 3/20 0.34
GLA P06280 1/20 0.34
MAPK13 O15264 1/20 0.34
MAPK11 Q15759 1/20 0.34
HSD17B10 Q99714 1/20 0.33
BRAF P15056 1/20 0.33
SYK P43405 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6163413 0.81 MAPK14 (0.53) MAPK14RAF1NPC1POLBRAB9A
SCHEMBL6163825 0.80 MAPK14 (0.51) MAPK14RAF1NPC1POLBRAB9A
SCHEMBL7665705 0.79 MAPK14 (0.50) MAPK14RAF1ALDH1A1MAPK12TNF
SCHEMBL6162310 0.78 MAPK14 (0.58) MAPK14RAF1MAPK12TNFHCK
SCHEMBL6163672 0.77 MAPK14 (0.53) MAPK14RAF1MAPK12TNFHCK
SCHEMBL6165061 0.74 MAPK14 (0.51) MAPK14RAF1GAAMAPK12MAPK13
SCHEMBL6161478 0.73 MAPK14 (0.61) MAPK14RAF1GAABRAFSYK
SCHEMBL6163294 0.72 MAPK14 (0.61) MAPK14RAF1MAPK12TNFHCK
SCHEMBL6160851 0.70 MAPK14 (0.50) MAPK14RAF1MAPK12TNFHCK
SCHEMBL6165444 0.69 MAPK14 (0.47) MAPK14RAF1MAPK12TNFHCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1163236-B1 AROMATIC HETEROCYCLIC COMPOUNDS AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM PHARMA (US) 2005-11-09 EP disclosed
US-6476023-B1 Aromatic heterocyclic compounds as anti-inflammatory agents BOEHRINGEN INGELHEIM PHARMACEUTICALS, INC. 2002-11-05 US disclosed
EP-1163236-A1 AROMATIC HETEROCYCLIC COMPOUNDS AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2001-12-19 EP disclosed
US-6297381-B1 INHIBIT THE RELEASE OF INFLAMMATORY CYTOKINES SUCH AS INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR, UREAS OR THIOUREAS SUBSTITUTED BY A PYRROLE OR THIOPHENE BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2001-10-02 US disclosed
WO-2000055152-A1 AROMATIC HETEROCYCLIC COMPOUNDS AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2000-09-21 WO disclosed